Eosinophil cationic protein in patients with fascioliasis: Its probable effects on symptoms and signs

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 5, 2006, Pages 346-349

  Demirci, Mustafa ^a,c   Kaya, Selcuk ^a   Cetin, Emel Sesli ^a   Aridogan, Buket Cicioglu ^a   Korkmaz, Metin ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; LIVER ENZYME;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EOSINOPHILIA; FASCIOLIASIS; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URTICARIA; WEIGHT REDUCTION;

ABDOMINAL PAIN; ADULT; ANIMALS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILIA; EOSINOPHILS; FASCIOLIASIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; URTICARIA; WEIGHT LOSS;

EID: 33744823840     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500444678     Document Type: Article

References (24)

1. Arjona, R and Riancho, JA and Aguado, JM and Salesa, R and Gonzalez Macias, J. (1995) Fascioliasis in developed countries: A review of classic and aberrant forms of the diseases Medicine, 74, pp. 13-23.
2. Demirci, M and Korkmaz, M and Kaya, S and Kuman, A. (2003) Fascioliasis in eosinophilic patients in Isparta region of Turkey Infect, 31, pp. 15-8.
3. Price, TA and Tuazon, CA and Simon, GL. (1993) Fascioliasis: Case reports and review Clin Infec Diseases, 17, pp. 426-30.
4. Osman, MM and Rashwan, E and Farag, HF. (1995) Phagocytic activity of neutrophils in human fascioliasis before and after treatment J Egypt Soc Parasitol, 25, pp. 321-7.
5. Weller, PF. (1997) Human eosinophils Clinical Immunology, 100, pp. 283-8.
6. Butterworth, AE and Sturrock, RF and Houba, V and Mahmoud, AA and Sher, A and Rees, PH. (1975) Eosinophils as mediators of antibody dependent damage to schistosomula Nature, 256, pp. 727-9.
7. Kleine, TJ and Gleich, GJ and Lewis, SA. (1998) Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium Am J Physiol, 275, pp. 93-103.
8. Fredens, K and Dybdahl, H and Dahl, R and Baandrup, U. (1988) Extracellular deposits of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage APMIS, 96, pp. 711-9.
9. Venge, P and Bystrom, JM and Carlson, M and Hakansson, L and Karawacjzyk, M and Peterson, C and (1999) Eosinophil cationic protein (ECP): Molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease Clinical and Experimental Allergy, 29, pp. 1172-86.
10. Domachowske, JB and Dyer, KD and Adams, AG and Leto, TL and Rosenberg, HF. (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity Nucl Acids Res, 26, pp. 3358-63.
11. Lehrer, RI and Szklarez, D and Barton, A and Ganz, T and Hamann, KJ and Gleich, GJ. (1989) Anti-bacterial properties of eosinophil major basic protein (MBP) and eosinophil cationic protein (ECP) J Immunol, 142, pp. 4428-34.
12. Young, JD and Peterson, CG and Venge, P and Cohn, ZA. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein Nature, 321, pp. 613-6.
13. Carlos Perez, C and Vives, R and Montes, M and Ostiz, S. (2000) Recurrent eosinophilic panniculitis associated with Fasciola hepatica infection J Am Acad Dermatol, 42, pp. 900-2.
14. Shaker, ZA and Demerdash, ZA and Mansour, WA and Hassanein, HI and El-Baz, HG and Gindy, H. (1994) Evaluation of specific Fasciola antigen in the immunodiagnosis of human fascioliasis in Egypt J Egypt Soc Parasitol, 24, pp. 463-70.
15. Pulpeiro, JR and Armesto, V and Yesela, J and Corredoira, J. (1991) Fascioliasis: Findings in 15 patients The British J Radiology, 64, pp. 798-801.
16. Espana, A and Sanz, ML and Sola, J and Gil, P. (1999) Wells' syndrome (eosinophilic cellulitis): Correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5 British Journal of Dermatology, 140, pp. 127-30.
17. Cox, NH and Venge, P and Friedmann, PS. (1993) Eosinophilic cationic protein in dermatitis herpetiformis, bullous pemphigoid, and other blistering disorders Eur J Dermatol, 3, pp. 294-7.
18. Czech, W and Schaller, J and Schopf, E and Kapp, A. (1993) Granulocyte activation in bullous diseases: Release of granular proteins in bullous pemphigoid and pemphigus vulgaris J Am Acad Dermatol, 29, pp. 210-5.
19. Barck, C and Lundahl, J and Hallden, G and Bylin, G. (2005) Total eosinophil cationic protein levels in induced sputum as a marker of changes in eosinophilic inflammation in a patient with allergic asthma Ann Allergy Asthma Immunol, 95, pp. 86-92.
20. Spry, CJ and Davies, J and Tai, PC and Olsen, EG and Oakley, CM and Goodwin, JF. (1983) Clinical features of 15 patients with the hypereosinophilic syndrome Q J Med, 52, pp. 1-22.
21. De Jesus, AR and Silva, A and Santana, LB and Magalhaes, A and De Jesus, AA and De Almeida, RP and (2002) Clinical and immunological evaluation of 31 patients with acute schistosomiasis J Infect Dis, 185, pp. 98-105.
22. Koller, DY and Gotz, M and Eichler, I and Urbanek, R. (1994) Eosinophilic activation in cystic fibrosis Thorax, 49, pp. 496-9.
23. Fredens, K and Dahl, R and Venge, P. (1982) The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein-X Allergy Clin Immunol, 70, pp. 361-6.
24. Kuberski T. (1979) Eosinophils in the cerebrospinal fluid Ann Intern Med, 91, pp. 70-5.